Current Value
$1.321 Year Return
Current Value
$1.321 Year Return
Yahoo
We recently published a list of Top 8 AI News Updates Driving Markets Today. In this article, we are going to take a look at where Predictive Oncology Inc. (NASDAQ:POAI) stands against other top AI news updates driving markets today. The AI race switched gears after Chinese AI startup DeepSeek announced on March 25th that […]
Yahoo
Company successfully developed predictive models derived from 21 unique compounds from the Natural Products Discovery Core at the University of Michigan Tumor response models for novel compounds represent true drug discovery using Predictive's active machine learning platform PITTSBURGH, March 25, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today that it has successfully developed predictive models derived from 21 unique compo
Yahoo
Deal positions STREAMWAY® Systems with an established market leader to drive accelerating growth Transaction allows Predictive Oncology to be highly focused on its core AI-driven drug discovery capabilities and integrate seamlessly with Renovaro Biosciences PITTSBURGH, March 20, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today that it has completed the sale of assets related to its wholly owned subsidiary, Skyline Medical Inc
Yahoo
Company Commits the First Tranche of Financing to Initiate the Integration of AI/ML Platform Technologies, Core Laboratory Capabilities and Business Development Efforts in Europe and the United States Renovaro’s Strategic Acquisition of BioSymetrics Vastly Expands Biomarker and Drug Discovery Opportunities and the Development of Diagnostic Applications in Oncology LOS ANGELES, March 03, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation
Yahoo
Predictive receives first tranche of financing to initiate integration of AI/ML platform technologies, core laboratory capabilities and business development efforts in Europe and the United States Renovaro’s recent strategic acquisition of BioSymetrics vastly expands Predictive Oncology’s biomarker and drug discovery opportunities and the development of diagnostic applications in oncology Merger expected to enhance shareholder value, accelerate business development efforts and solidify positioni
Yahoo
PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), a leader in AI-driven drug discovery and biologics, today closed its previously announced registered direct offering for the purchase and sale of 363,336 shares of common stock at a purchase price of $1.50 per share priced at-the-market under Nasdaq rules. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The gross proceeds to the Company fr
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EW | -37.83% | $42.20B | -22.54% | 0.00% |
CHD | -26.08% | $26.66B | +5.00% | 1.03% |
CL | -25.00% | $75.88B | +6.19% | 2.07% |
RSG | -24.92% | $76.45B | +29.37% | 0.92% |
CLX | -24.04% | $18.19B | +0.54% | 3.24% |
INVH | -22.33% | $21.22B | -0.32% | 3.31% |
ALL | -21.47% | $54.44B | +18.46% | 1.83% |
WM | -20.98% | $94.32B | +11.47% | 1.30% |
POST | -20.84% | $6.54B | +11.31% | 0.00% |
PG | -20.79% | $397.45B | +8.55% | 2.32% |
GIS | -20.10% | $32.41B | -14.20% | 3.90% |
CAG | -19.75% | $12.59B | -9.22% | 5.19% |
LKQ | -18.81% | $11.22B | -16.85% | 2.88% |
OHI | -18.60% | $10.68B | +21.25% | 6.79% |
DUK | -18.04% | $93.55B | +25.45% | 3.37% |
MAA | -17.87% | $19.64B | +30.79% | 3.57% |
FPI | -17.77% | $508.19M | +3.63% | 2.20% |
KMB | -17.52% | $47.39B | +13.36% | 3.37% |
MDT | -17.31% | $113.97B | +4.54% | 3.16% |
REG | -17.03% | $13.57B | +25.11% | 3.80% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
COLL | 0.01% | $944.57M | -23.95% | 0.00% |
NSP | 0.03% | $3.32B | -16.89% | 2.82% |
ATNI | -0.03% | $312.72M | -31.39% | 4.98% |
DOLE | 0.03% | $1.39B | +27.04% | 2.18% |
ABUS | 0.03% | $672.09M | +20.21% | 0.00% |
TYRA | 0.03% | $438.99M | -50.85% | 0.00% |
AFCG | 0.05% | $129.25M | -28.89% | 25.02% |
CCEP | -0.05% | $40.28B | +26.77% | 2.31% |
ZCMD | 0.05% | $32.02M | -17.53% | 0.00% |
LNG | -0.05% | $52.48B | +48.22% | 0.83% |
TNK | 0.06% | $1.31B | -35.53% | 2.66% |
MTN | 0.06% | $6.06B | -28.68% | 5.63% |
BRK.B | -0.06% | $1.16T | +27.96% | 0.00% |
CMPR | 0.07% | $1.17B | -51.13% | 0.00% |
OXSQ | 0.08% | - | - | 16.50% |
RLI | 0.08% | $7.41B | +12.56% | 1.25% |
MGM | 0.09% | $8.78B | -34.22% | 0.00% |
HMN | 0.09% | $1.78B | +18.91% | 3.23% |
PCVX | 0.10% | $4.34B | -48.25% | 0.00% |
SGRY | 0.10% | $3.00B | -14.37% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTC | 26.42% | $3.28B | 0.15% |
ARKG | 24.55% | $936.86M | 0.75% |
PBW | 22.34% | $213.72M | 0.65% |
IPO | 22.19% | $130.61M | 0.6% |
XTN | 22.16% | $160.05M | 0.35% |
ARKK | 22.10% | $5.03B | 0.75% |
CPRJ | 21.69% | $48.38M | 0.69% |
ARKX | 20.65% | $258.10M | 0.75% |
ARKQ | 20.36% | $822.91M | 0.75% |
SLX | 20.27% | $75.44M | 0.56% |
PRNT | 20.12% | $73.21M | 0.66% |
WCLD | 20.11% | $400.75M | 0.45% |
XES | 19.87% | $185.92M | 0.35% |
QCLN | 19.69% | $399.59M | 0.59% |
ACES | 19.49% | $86.87M | 0.55% |
KOMP | 19.39% | $1.95B | 0.2% |
ROBT | 19.27% | $420.42M | 0.65% |
SKYY | 19.16% | $3.12B | 0.6% |
BATT | 19.03% | $56.55M | 0.59% |
IWC | 19.01% | $797.08M | 0.6% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RIET | 0.01% | $88.71M | 0.5% |
TPYP | -0.02% | $753.12M | 0.4% |
GDXJ | -0.05% | $5.34B | 0.52% |
INDA | 0.07% | $8.84B | 0.62% |
AFIF | 0.10% | $135.91M | 1.11% |
LDSF | -0.10% | $110.41M | 0.75% |
VWOB | 0.19% | $5.08B | 0.15% |
CLOZ | -0.26% | $789.73M | 0.5% |
BWX | 0.27% | $990.94M | 0.35% |
WTMF | 0.27% | $157.25M | 0.65% |
IBHG | 0.29% | $273.75M | 0.35% |
SLQD | -0.30% | $2.23B | 0.06% |
IBTF | 0.35% | $2.22B | 0.07% |
PHB | 0.36% | $329.02M | 0.5% |
MNA | -0.36% | $222.56M | 0.77% |
MINT | 0.39% | $13.22B | 0.35% |
FVD | -0.39% | $9.16B | 0.6% |
EMLP | 0.42% | $3.30B | 0.96% |
CPSJ | 0.42% | $32.91M | 0.69% |
JUCY | 0.42% | $306.51M | 0.6% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LTM | 47.14% | $9.43B | -100.00% | <0.01% |
FUBO | 38.34% | $1.08B | +101.92% | 0.00% |
PYCR | 33.08% | $4.09B | +25.00% | 0.00% |
DOV | 29.51% | $24.54B | +2.68% | 1.25% |
OII | 27.67% | $2.27B | -11.60% | 0.00% |
LPX | 27.32% | $6.53B | +13.85% | 1.22% |
FCNCA | 26.88% | $25.16B | +17.60% | 0.43% |
CRNC | 26.50% | $363.74M | -42.76% | 0.00% |
RES | 26.25% | $1.24B | -28.23% | 3.26% |
SYPR | 25.93% | $37.52M | -3.55% | 0.00% |
CLB | 25.68% | $698.66M | -14.06% | 0.31% |
ARCT | 25.51% | $276.62M | -68.85% | 0.00% |
NTCT | 25.46% | $1.55B | +4.10% | 0.00% |
MCRI | 25.37% | $1.46B | +8.09% | 1.61% |
CRS | 25.31% | $9.36B | +154.55% | 0.47% |
SAIA | 25.28% | $9.88B | -35.89% | 0.00% |
SEG | 25.09% | $269.93M | -17.45% | 0.00% |
VMI | 24.94% | $5.95B | +34.58% | 0.90% |
WH | 24.80% | $7.17B | +24.90% | 1.78% |
PLXS | 24.71% | $3.52B | +34.50% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -24.05% | $416.76M | 1.43% |
CCOR | -17.70% | $64.12M | 1.18% |
IYK | -16.91% | $1.53B | 0.4% |
GBIL | -15.29% | $6.30B | 0.12% |
REZ | -15.10% | $858.68M | 0.48% |
XLP | -14.11% | $16.87B | 0.09% |
BIL | -12.87% | $41.88B | 0.1356% |
FTXG | -12.75% | $26.06M | 0.6% |
FSTA | -12.73% | $1.30B | 0.084% |
VDC | -12.17% | $7.46B | 0.09% |
TBLL | -11.92% | $2.13B | 0.08% |
XBIL | -11.25% | $706.15M | 0.15% |
STPZ | -11.10% | $427.83M | 0.2% |
TAIL | -10.99% | $87.65M | 0.59% |
FXG | -10.95% | $292.47M | 0.63% |
TBIL | -10.87% | $5.39B | 0.15% |
SHV | -10.82% | $20.16B | 0.15% |
SPLV | -10.73% | $7.85B | 0.25% |
VNLA | -10.28% | $2.55B | 0.23% |
GOVT | -10.19% | $26.61B | 0.05% |